What does Ampio Pharmaceuticals, Inc. do?

Jun 22 2025 06:43 PM IST
share
Share Via
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing therapies for inflammatory conditions. As of December 2023, it has a market cap of $0 million and reported a net profit loss of $2 million.
Overview:
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing therapies for prevalent inflammatory conditions within the Pharmaceuticals & Biotechnology industry. Financial Snapshot: Most recent Net Profit: -2 Million (Quarterly Results - Dec 2023) Market cap: USD 0.00 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -1.14 Return on Equity: -265.51% Price to Book: 0.00 Contact Details: Address: 373 Inverness Pkwy Ste 200, ENGLEWOOD CO: 80112-5898 Tel: 1 720 4376500 Website: http://ampiopharma.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Ampio Pharmaceuticals, Inc. overvalued or undervalued?
Jun 25 2025 08:59 AM IST
share
Share Via
How big is Ampio Pharmaceuticals, Inc.?
Jun 22 2025 06:01 PM IST
share
Share Via